P. M. Houtman

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study

Suzanne Arends, Elisabeth Brouwer, E. van der Veer et al. · Arthritis Research & Therapy · 2011 · 223 citations · Full text

Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients

M.K. Reinders, Eric N. van Roon, P. M. Houtman et al. · Clinical Rheumatology · 2007 · 91 citations · Full text

Urology, Medicine, Gouty Arthritis +4

Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.

P. M. Houtman, Cornelis Kallenberg, Fidler et al. · PubMed · 1986 · 90 citations

Primary Rp, Dermatoglyphic, Enlarged Loops +8

Hepatic injury caused by benzbromarone

Melanie M. van der Klauw, P. M. Houtman, Bruno H. Stricker et al. · Journal of Hepatology · 1994 · 80 citations

Hepatology, Medicine, Liver Physiology +9

The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis.

Suzanne Arends, H. R. Lebbink, Anneke Spoorenberg et al. · PubMed · 2010 · 62 citations